← Open Payments lookup

KAITLYN SROKA: Open Payments

NPI 1750087185 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$828 in 42 payments from 12 companies in 2025. Trend: 2023 $113 · 2024 $754 · 2025 $828

Food & beverage: $828
CompanyPaymentsAmount
ABBVIE INC.13$223
E.R. Squibb & Sons, L.L.C.4$85
Vanda Pharmaceuticals Inc.3$83
Axsome Therapeutics, Inc.4$82
Janssen Pharmaceuticals, Inc4$81
Teva Pharmaceuticals USA, Inc.3$53
Otsuka America Pharmaceutical, Inc.3$52
Lundbeck LLC2$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$41
Takeda Pharmaceuticals U.S.A., Inc.2$38

Products named: VRAYLAR, COBENFY, Auvelity, REXULTI, HETLIOZ, SPRAVATO, CAPLYTA, TRINTELLIX.

Industry payments across MD — which companies pay providers there.